Literature DB >> 15389823

Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy.

Venkatasubramaniam S Kalambur1, Hemchandra Mahaseth, John C Bischof, Miroslaw C Kielbik, Thomas E Welch, Asa Vilbäck, David J Swanlund, Robert P Hebbel, John D Belcher, Gregory M Vercellotti.   

Abstract

Vascular inflammation, secondary to ischemia-reperfusion injury, may play an essential role in vaso-occlusion in sickle cell disease (SCD). To investigate this hypothesis, dorsal skin fold chambers (DSFCs) were implanted on normal and transgenic sickle mice expressing human alpha and beta(s)/beta(s-Antilles) globin chains. Microvessels in the DSFC were visualized by intravital microscopy at baseline in ambient air and after exposure to hypoxia-reoxygenation. The mean venule diameter decreased 9% (P < 0.01) in sickle mice after hypoxia-reoxygenation but remained constant in normal mice. The mean RBC velocity and wall shear rate decreased 55% (P < 0.001) in sickle but not normal mice after hypoxia-reoxygenation. None of the venules in normal mice became static at any time during hypoxia-reoxygenation; however, after 1 hr of hypoxia and 1 hr of reoxygenation, 11.9% of the venules in sickle mice became static (P < 0.001). After 1 hr of hypoxia and 4 hr of reoxygenation, most of the stasis had resolved; only 3.6% of the subcutaneous venules in sickle mice remained static (P = 0.01). All of the venules were flowing again after 24 hr of reoxygenation. Vascular stasis could not be induced in the subcutaneous venules of sickle mice by tumor necrosis factor alpha (TNF-alpha). Leukocyte rolling flux and firm adhesion, manifestations of vascular inflammation, were significantly higher at baseline in sickle mice compared to normal (P < 0.01) and increased 3-fold in sickle (P < 0.01), but not in normal mice, after hypoxia-reoxygenation. Plugs of adherent leukocytes were seen at bifurcations at the beginning of static venules. Misshapen RBCs were also seen in subcutaneous venules. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15389823     DOI: 10.1002/ajh.20143

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  34 in total

1.  Serial assessment of laser Doppler flow during acute pain crises in sickle cell disease.

Authors:  Patricia Ann Shi; Deepa Manwani; Olugbenga Olowokure; Vijay Nandi
Journal:  Blood Cells Mol Dis       Date:  2014-05-21       Impact factor: 3.039

2.  Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

3.  Critical role of C5a in sickle cell disease.

Authors:  Gregory M Vercellotti; Agustin P Dalmasso; Terry R Schaid; Julia Nguyen; Chunsheng Chen; Marna E Ericson; Fuad Abdulla; Trevor Killeen; Margaret A Lindorfer; Ronald P Taylor; John D Belcher
Journal:  Am J Hematol       Date:  2019-01-03       Impact factor: 10.047

4.  Visualization of in vitro deep blood vessels using principal component analysis based laser speckle imaging.

Authors:  Jose Angel Arias-Cruz; Roger Chiu; Hayde Peregrina-Barreto; Ruben Ramos-Garcia; Teresita Spezzia-Mazzocco; Julio C Ramirez-San-Juan
Journal:  Biomed Opt Express       Date:  2019-03-25       Impact factor: 3.732

5.  Not simply misshapen red cells: multimolecular and cellular events in sickle vaso-occlusion.

Authors:  Gregory M Vercellotti; John D Belcher
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

6.  The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.

Authors:  Robert P Hebbel; Gregory M Vercellotti; Betty S Pace; Anna N Solovey; Rahn Kollander; Chine F Abanonu; Julia Nguyen; Julie V Vineyard; John D Belcher; Fuad Abdulla; Shadé Osifuye; John W Eaton; Robert J Kelm; Arne Slungaard
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

7.  Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease.

Authors:  Gregory M Vercellotti; Ping Zhang; Julia Nguyen; Fuad Abdulla; Chunsheng Chen; Phong Nguyen; Carlos Nowotny; Clifford J Steer; Ann Smith; John D Belcher
Journal:  Mol Med       Date:  2016-07-19       Impact factor: 6.354

Review 8.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

9.  Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease.

Authors:  Joan D Beckman; John D Belcher; Julie V Vineyard; Chunsheng Chen; Julia Nguyen; M Osita Nwaneri; M Gerard O'Sullivan; Evin Gulbahce; Robert P Hebbel; Gregory M Vercellotti
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

10.  Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice.

Authors:  John D Belcher; Hemachandra Mahaseth; Thomas E Welch; Leo E Otterbein; Robert P Hebbel; Gregory M Vercellotti
Journal:  J Clin Invest       Date:  2006-02-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.